<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02420431</url>
  </required_header>
  <id_info>
    <org_study_id>156862 (RP-PG-1211-20011)</org_study_id>
    <nct_id>NCT02420431</nct_id>
  </id_info>
  <brief_title>Treating Depression and Anxiety in the Cardiac Rehabilitation Pathway</brief_title>
  <acronym>PATHWAY</acronym>
  <official_title>Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in the Cardiac Rehabilitation Pathway: A Single-blind Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Manchester Mental Health &amp; Social Care Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manchester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac rehabilitation (CR) services aim to improve heart disease patients' health and&#xD;
      quality of life, and reduce the risk of further cardiac events. Depression and anxiety&#xD;
      (distress) are common among CR patients: 37% of patents have significant anxiety and/or&#xD;
      depressive symptoms. Distressed patients are at greater risk of death, further cardiac events&#xD;
      and poorer quality of life than those without distress and they use more healthcare.&#xD;
      Available drug and psychological treatments have only small effects on distress and quality&#xD;
      of life, and no effects on physical health. Therefore, it is essential that more effective&#xD;
      treatments for depression and anxiety are integrated into CR services. Extensive evidence&#xD;
      shows that a particular style of thinking dominated by rumination (dwelling on the past) and&#xD;
      worry maintains emotional distress. A psychological intervention (metacognitive therapy) that&#xD;
      reduces this style of thinking alleviates depression and anxiety in mental health settings.&#xD;
      The investigators aim to conduct a pilot trial of the group intervention and in work stream 2&#xD;
      the investigators will undertake a full-scale trial to evaluate whether adding the group&#xD;
      intervention to standard CR is more effective at alleviating anxiety and depression than&#xD;
      standard CR alone.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">August 2019</completion_date>
  <primary_completion_date type="Actual">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>Baseline pre treatment, four-month post baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of Events Scale -revised</measure>
    <time_frame>Baseline, four-month post baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metacognitions Questionnaire 30</measure>
    <time_frame>Baseline, four-month post baseline, 12 month follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Attentional Syndrome scale (CAS-1)</measure>
    <time_frame>Baseline, four-month post baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life (EQ-5D)</measure>
    <time_frame>Baseline, four-month post baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic Patient Questionnaire</measure>
    <time_frame>Baseline, 4 month follow-up, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>12 month follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">332</enrollment>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Cardiac Rehabilitation</condition>
  <arm_group>
    <arm_group_label>metacognitive therapy plus CR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group psychological treatment focused on reducing worry and rumination and modifying beliefs about thinking in addition to treatment as usual (standard cardiac rehabilitation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CR alone (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual group-based cardiac rehabilitation (treatment as usual) involving stress management, exercise, education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Metacognitive Therapy</intervention_name>
    <description>Metacognitive therapy (MCT) helps clients to identify episodes of worry and rumination in response to negative thoughts and bring these responses under control. This process is facilitated by exercises that enhance the flexibility of attention control, challenge unhelpful beliefs about thinking and enable new relationships with thoughts</description>
    <arm_group_label>metacognitive therapy plus CR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cardiac Rehabilitation (treatment as usual)</intervention_name>
    <description>Stress management, relaxation training, exercise and dietary advice.</description>
    <arm_group_label>CR alone (control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heart disease patients referred to CR with: Acute coronary syndrome&#xD;
&#xD;
          -  Following revascularisation; stable heart failure&#xD;
&#xD;
          -  Stable angina, implanted cardioverter defibrillators&#xD;
&#xD;
          -  Heart valve repair/replacement&#xD;
&#xD;
          -  Heart transplantation and ventricular assist devices&#xD;
&#xD;
          -  Adult congenital heart disease&#xD;
&#xD;
          -  Must have a score of 8 or more on either the depression or anxiety subscale of the&#xD;
             HADS&#xD;
&#xD;
          -  Competent level of English language skills&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment which precludes informed consent/ability to participate&#xD;
&#xD;
          -  Acute suicidality&#xD;
&#xD;
          -  Active psychotic disorders&#xD;
&#xD;
          -  Current drug/alcohol abuse&#xD;
&#xD;
          -  Concurrent psychological intervention for emotional distress&#xD;
&#xD;
          -  Antidepressant or anxiolytic medication initiated in previous 8 weeks&#xD;
&#xD;
          -  Life expectancy of less than 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Wells, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Macclesfield District General Hospital</name>
      <address>
        <city>Macclesfield</city>
        <state>Cheshire</state>
        <zip>SK10 3BL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Manchester University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>Lancashire</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of South Manchester NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>Lancashire</state>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennine Acute Hospitals NHS Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M8 5RB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stepping Hill Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>SK2 7JE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 9, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2015</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manchester</investigator_affiliation>
    <investigator_full_name>Adrian Wells</investigator_full_name>
    <investigator_title>Professor of Clinical and Experimental Psychopathology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

